BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 5096207)

  • 21. [Evaluation of routine serochemical methods for the study of liver involvement in diabetes mellitus].
    Heller H
    Z Gesamte Inn Med; 1971 May; 26(10):Suppl:120-4. PubMed ID: 5131405
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of hepatic diseases in ambulatory medicine. Multicenter studies].
    Martines G; Mingrino GC; Cagnetta G; Copponi V
    Clin Ter; 1980 Jan; 92(1):33-58. PubMed ID: 7449307
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trial on a new combination of hepatoprotecting agents.
    Barlattani M
    Arzneimittelforschung; 1970 Apr; 20(4):560-5. PubMed ID: 4192590
    [No Abstract]   [Full Text] [Related]  

  • 24. [Epidemiology of chronic liver diseases in the picture of complex biochemical medical check-ups].
    Ehrke D; Bohnensack G; Depersdorff J; Friedemann H; Linneke P; Schmudlach HO; Storm H; Thiele HJ
    Z Gesamte Inn Med; 1974 Dec; 29(23):969-72. PubMed ID: 4464720
    [No Abstract]   [Full Text] [Related]  

  • 25. [Enzyme diagnosis and liver diseases].
    Schmidt E; Schmidt FW
    Schweiz Med Wochenschr; 1969 Apr; 99(15):514-21. PubMed ID: 5784493
    [No Abstract]   [Full Text] [Related]  

  • 26. [Liver morphology and liver function in delirium tremens].
    Irsigler K; Kryspin-Exner K; Mildschuh W; Pointner H; Schmidt P
    Dtsch Med Wochenschr; 1971 Jan; 96(1):9-13. PubMed ID: 5540002
    [No Abstract]   [Full Text] [Related]  

  • 27. [The antihepatotoxic effect of silymarine on lipid metabolism in the rat disturbed by phalloidine intoxication].
    Schriewer H; Kastrup W; Wiemann W; Rauen HM
    Arzneimittelforschung; 1975 Feb; 25(2):188-94. PubMed ID: 1173031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of prophylactic efficacy of silymarin in CC14-induced hepatotoxicity.
    Williams DE; Priestly BG
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):185-94. PubMed ID: 4733996
    [No Abstract]   [Full Text] [Related]  

  • 29. Liver function during amantadine hydrochloride medication in compensated liver disease.
    Schnack H; Wewalka F; Guttmann G
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):185-7. PubMed ID: 5800713
    [No Abstract]   [Full Text] [Related]  

  • 30. Aspartic acid in the treatment of chronic hepatitis.
    Fodor O; Barbarino F; Cotul S
    Acta Hepatosplenol; 1971; 18(5):383-94. PubMed ID: 5112055
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum lactic dehydrogenase and its isoenzymes in hepatic disorders.
    Ramdeo IN; Joshi KC
    Am J Gastroenterol; 1971 May; 55(5):459-65. PubMed ID: 5556626
    [No Abstract]   [Full Text] [Related]  

  • 32. Pimozide (R6238) in chronic schizophrenia: double blind trial.
    Gowardman M; Barrer B; Brown RA
    N Z Med J; 1973 Dec; 78(504):487-91. PubMed ID: 4591853
    [No Abstract]   [Full Text] [Related]  

  • 33. [Favorable development of parenchymal liver diseases].
    Hofstetter JR
    Schweiz Med Wochenschr; 1968 Feb; 98(5):140-3. PubMed ID: 4173850
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of essential phospholipids following acute experimental CCl4 liver injury].
    Rauen HM; Schriewer H; Gebauer B; Abu Tair M
    Arzneimittelforschung; 1973 Sep; 23(9):1332-4. PubMed ID: 4801231
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biochemical indices of the blood serum in various liver diseases].
    Tokarskaia ZB; Chernova GV; Dorozhko VA
    Ter Arkh; 1974; 46(4):53-8. PubMed ID: 4139774
    [No Abstract]   [Full Text] [Related]  

  • 36. [Liver function in gout and in asymptomatic hyperuricemia. Studies on 79 cases].
    Klein WW
    Z Rheumaforsch; 1971; 30(7):230-5. PubMed ID: 5093617
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnostic significance of serum -glucuronidase. 3. Behavior of serum -glucuronidase activity in liver diseases in comparison to other clinical and chemical study results].
    Nilius R
    Z Gesamte Inn Med; 1971 Jun; 26(12):384-93. PubMed ID: 5122587
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anabolic steroids and liver diseases].
    Wewalka F
    Wien Med Wochenschr; 1967 Mar; 117(12):293-9. PubMed ID: 4871957
    [No Abstract]   [Full Text] [Related]  

  • 39. [Morphological, serum enzyme and plasma protein fraction correlates in various hepatic diseases].
    Peracino A; Marcovina S; Miti L
    G Clin Med; 1971 May; 52(5):369-90. PubMed ID: 5143393
    [No Abstract]   [Full Text] [Related]  

  • 40. [Efficient liver function test].
    Kühn HA
    Med Klin; 1973 Apr; 68(17):539-44. PubMed ID: 4145124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.